cream  

futecline
 
 
Overview
Product Benefits  
Development  
Intellectual Property  
About FUTECNZ  
Technical Details  
Licensing  
Contact  
 

Description / Frequently Asked Questions
Abzorba technology is made up of three essential parts.

   1. the formulations.
   2. the manufacturing machinery (unique)
   3. the know-how.

Abzorba technology cannot be handled by established contract manufacturers because of the very specific and non-normal production techniques and equipment required. Specific knowledge and machinery has been developed to handle this technology and is a trade secret, proprietary to the developer. We know anhydrous Abzorba organogel end-products are un-matched among the 'status quo' and are very effective in delivering all of the beneficial and proprietary claims listed. Comparative studies are available.

1 Q Is this technology patentable?
  A Yes.



2 Q Has there been any allergic reactions to our products?
  A No. Thousands of products have been trialled and not a single complaint nor allergic reaction reported.



3 Q Are any products registered and where?
  A Previously yes, an early brand of the sunscreen was licensed to TGA Australia.



4 Q Is it effective in drug delivery?
  A Anecdotally very strong evidence, with clinical trials still to be done.



5 Q Infection eradication
  A Yes.



6 Q Is the R&D complete?
  A No. Abzorba core technology product will take many actives (drugs) into skin and there is vast R&D opportunities ready for your specific testing.


 
  Overview Product BenefitsDevelopmentIntellectual PropertyAbout FUTECNZ l Technical Details l  LicensingContact